Sonavex

company

About

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$1M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$12.77M
Sonavex has raised a total of $12.77M in funding over 2 rounds. Their latest funding was raised on May 25, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 25, 2022 Grant $1.70M 1 National Institutes of Health Detail
Aug 29, 2019 Grant $3M 1 National Institutes of Health Detail
Mar 9, 2018 Series A $1M 1 Detail
Apr 24, 2017 Series A $4.50M 1 Detail
Sep 6, 2016 Grant $1.39M 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
4
5
Sonavex is funded by 5 investors. National Institutes of Health and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
National Science Foundation Yes Grant
Gaingels Series A
TEDCO Series A
BlueJay Syndicate Seed